Emergent BioSolutions (EBS) Change in Receivables (2010 - 2026)
Emergent BioSolutions (EBS) posted Change in Receivables of $68.8 million for Q2 2026, up 76.86% on a QoQ basis from $38.9 million in Q1 2026, and up 158.06% year-over-year from $26.7 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Change in Receivables (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Change in Receivables for 17 years, with the latest figure at $68.8 million in Q2 2026.
- On a quarterly basis, Change in Receivables rose 158.06% year-over-year to $68.8 million in Q2 2026; TTM through Jun 2026 was $127.4 million, a 352.78% increase from a year earlier, with the FY2025 full-year figure at -$25.5 million, down 204.51% from the prior year.
- Change in Receivables was $68.8 million for Q2 2026 at Emergent BioSolutions, up from $38.9 million in the prior quarter.
- The five-year high for Change in Receivables was $132.4 million in Q2 2023, with the low at -$118.5 million in Q2 2025.
- Average Change in Receivables over 5 years is $561111.1, with a median of -$3.3 million recorded in 2022.
- The largest YoY upside for Change in Receivables was 3410.0% in 2023 against a maximum downside of 569.08% in 2023.
- Over 5 years, Change in Receivables stood at -$35.6 million in 2022, then retreated by 3.65% to -$36.9 million in 2023, then jumped by 308.94% to $77.1 million in 2024, then sank by 167.32% to -$51.9 million in 2025, then surged by 232.56% to $68.8 million in 2026.
- The last three Change in Receivables figures came in at $68.8 million (Q2 2026), $38.9 million (Q1 2026), and -$51.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 1.18 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | - |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 117.58 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 68.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.80 Mn |
| Mar 31, 2026 | 38.90 Mn |
| Dec 31, 2025 | -51.90 Mn |
| Sep 30, 2025 | 71.60 Mn |
| Jun 30, 2025 | -118.50 Mn |
| Mar 31, 2025 | 73.30 Mn |
| Dec 31, 2024 | 77.10 Mn |
| Sep 30, 2024 | -82.30 Mn |
| Jun 30, 2024 | -20.40 Mn |
| Mar 31, 2024 | 50.00 Mn |
| Dec 31, 2023 | -36.90 Mn |
| Sep 30, 2023 | -71.30 Mn |
| Jun 30, 2023 | 132.40 Mn |
| Mar 31, 2023 | -2.60 Mn |
| Dec 31, 2022 | -35.60 Mn |
| Sep 30, 2022 | 15.20 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -93.70 Mn |
| Dec 31, 2021 | -98.50 Mn |
| Sep 30, 2021 | 80.00 Mn |
API Access
Emergent BioSolutions Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();